Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon- after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen

By Atzpodien J.   Lopez Hanninen E.   Kirchner H.   Franzke A.   Korfer A.   Volkenandt M.   Duensing S.   Schomburg A.   Chaitchik S.   Poliwoda H.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 876-881

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Dacarbazine, Cisplatin, Interferon- and High-dose Interleukin-2 in 'Poor-risk' Metastatic Melanoma

By Proebstle T.M.   Scheibenbogen C.   Sterry W.   Keilholz U.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1530-1533

Elsevier

Access to resources Recommend Favorite

Fotemustine and Dacarbazine Plus Recombinant Interferon Alpha2a in the Treatment of Advanced Melanoma

By Comella P.   Daponte A.   Casaretti R.   Ionna F.   Fiore F.   Presutti F.   Frasci G.   Caponigro F.   Gravina A.   Parziale A.P.   Mozzillo N.   Comella G.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1326-1329

Elsevier

Access to resources Recommend Favorite

Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine

By Seeber A.   Binder M.   Steiner A.   Wolff K.   Pehamberger H.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2129-2131

Elsevier

Access to resources Recommend Favorite

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma

By Kivela T.   Suciu S.   Hansson J.   Kruit W.H.J.   Vuoristo M.-S.   Kloke O.   Gore M.   Hahka-Kemppinen M.   Parvinen L.-M.   Kumpulainen E.   Humblet Y.   Pyrhonen S.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1115-1120

Elsevier

Access to resources Recommend Favorite